Renal adenocarcinoma and end stage kidney disease.
Renal adenocarcinoma and end stage kidney disease.
复制标题
肾腺癌和终末期肾病。
DOI：
10.1016/s0022-5347(17)43271-x
复制
发表时间：
1987
影响因子：
6.6
通讯作者：
E. Weinman
中科院分区：
文献类型：
--
作者：
M. Boileau;R. Foley;S. Flechner;E. Weinman
终末期肾脏疾病与囊性变性和肾腺癌的关联在1977年首次被确认。从那时起，许多报道证实了这种关系。透析持续时间是最密切相关的危险因素。我们报告8例终末期肾脏疾病及肾腺癌。血液透析的中位持续时间约为1年，3例患者从未进行过血液透析。除透析时间以外的其他因素，如有毒代谢物、透析管毒素、多胺或其他致癌物，可能同样重要或更重要。(j . Urol。生物医学工程学报，38 (3):603-606,1987)
The association of end stage kidney disease with cystic degeneration and renal adenocarcinoma was first recognized in 1977. Since then a number of reports have confirmed this relationship. Duration of dialysis has been the most strongly associated risk factor. We report 8 cases of end stage kidney disease and renal adenocarcinoma. Median duration of hemodialysis was approximately 1 year, and 3 patients never had hemodialysis. Factors other than duration of dialysis, such as toxic metabolites, toxins from dialysis tubing, polyamines or other carcinogens, may be as or more important. (J. Urol., 138: 603–606, 1987)